Treatment of Atrofic Striae With Percutaneous Collagen Induction Therapy Versus Fractional Nonablative Laser

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

April 10, 2018

Study Completion Date

April 20, 2018

Conditions
Striae Distensae
Interventions
DEVICE

Nd-Yap 1340nm laser

Each part of the abdomen will be treated with a therapeutic modality. The ND-yap 1340-nm laser will be used in the following parameters: 90 mtz / cm2 nozzle, 90 mJ / mtz power, 2.5 Hz frequency, 3 ms pulse duration, 1 pass.

DEVICE

Microneedling

In the other segment of the abdomen, the dermaroller 2.5 mm will be applied, with ten to fifteen passes in the same direction and at least four crosses in the rolling areas.

Trial Locations (1)

90035903

Ana Paula Naspolini, Porto Alegre

All Listed Sponsors
collaborator

Associação Fundo de Incentivo à Pesquisa

OTHER

collaborator

MTO Importadora e Distribuidora

UNKNOWN

collaborator

Vydence Medical

UNKNOWN

collaborator

Aché Laboratórios Farmacêuticos Ltda

INDUSTRY

lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT03390439 - Treatment of Atrofic Striae With Percutaneous Collagen Induction Therapy Versus Fractional Nonablative Laser | Biotech Hunter | Biotech Hunter